University of Kentucky starts new clinical trial

The University of Kentucky will start a clinical trial for an anti-seizure injection. They will be testing an auto-injector that will allow medicine to enter into the bloodstream of a a seizing patient before the medicine of an IV begin to work. They will be testing both methods.

The UK research team was selected along with 16 other prominent research institutions across the nation to conduct the emergency medicine trial known as RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial) within the Neurological Emergencies Treatment Trials (NETT) Network. The network, formed by the National Institutes of Health, conducts large, simple clinical trials to reduce the burden of very acute injuries and illnesses affecting the brain, spinal cord, and peripheral nervous system.

For more on the story, read here.

Medical News Today: Researchers Find Relationship Between Brain Fluid And Adult Seizures

According to a new study published early online and in the December issue of Lancet Neurology, researchers better understand the disease mechanisms behind brain seizures that are due to the tapeworm-derived parasitic infection called neurocysticercosis. Their finding that the seizures are frequently associated with fluid or perlesional oedema (PO) around dead calcified cysticercal granulomas (immune cells) may lead to better possible treatment targets.

For more information on this study please visit: Medical News Today